查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1612809

心血管设备市场：按设备类型、适应症和最终用户划分 - 全球预测 2025-2030

Cardiovascular Devices Market by Device Type (Diagnostic & Monitoring Devices, Therapeutic & Surgical Devices), Indication (Cardiac Arrhythmia, Coronary Artery Disease, Heart Failure), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年心血管器械市场价值为536.9亿美元，预计2024年将达到575.5亿美元，复合年增长率为7.38%，到2030年将达到884亿美元。

心血管设备市场包括用于诊断、管理和治疗心血管疾病的各种医疗设备。这包括心电图等诊断设备、支架和心律调节器等治疗设备以及帮助追踪高血压等慢性病的监测设备。由于人口老化、久坐的生活方式以及糖尿病和肥胖症的增加，全球心血管疾病盛行率不断上升，推动了对心血管设备的需求。它用于医院、手术中心和居家医疗环境，主要由心臟病专家和其他专门从事心臟健康的医疗保健专业人员使用。越来越多地采用微创手术和智慧医疗设备的持续技术进步是关键的成长动力。关键的商机在于开发人工智慧驱动的诊断工具和个人化医疗中针对患者的解决方案，这与正在进行的数位医疗保健转型相一致。然而，高成本、严格的法律规范以及欠发达地区缺乏准入等限制因素构成了重大挑战。他们还面临医疗设备召回和连网型设备网路安全威胁等障碍。创新应着重于增强设备连接性以及与电子健康记录(EHR) 的集成，以促进更好的护理协调。需要探索的关键领域包括早期疾病检测的预测分析以及提高植入式装置的生物相容性和电池寿命。市场竞争激烈，维持技术领先地位需要在研发方面进行大量投资。公司应该探索与科技公司的合作关係，以促进产品创新和扩充性。此外，透过医疗保健专业人员培训计画扩大推广范围可以解决设备可操作性和维护方面的问题，并专注于医疗保健基础设施不发达的市场。

主要市场统计
基准年[2023] 536.9亿美元
预计年份 [2024] 575.5亿美元
预测年份 [2030] 884亿美元
复合年增长率（%） 7.38%

市场动态：揭示快速发展的心血管设备市场的关键市场洞察

供需的动态交互作用正在改变心血管设备市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 心血管疾病负担增加
    • 微创手术日益偏好青睐
    • 改善新兴国家的医疗设施并扩大医疗服务
  • 市场限制因素
    • 严格的监管政策和产品召回
  • 市场机会
    • 整合穿戴技术持续监测心臟健康
    • 持续研究心血管设备的生物相容性与材料科学
  • 市场挑战
    • 报销保单数量有限

波特五力：驾驭心血管设备市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心血管设备市场的外部影响

外部宏观环境因素在塑造心血管器械市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解心血管设备市场的竞争格局

心血管设备市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心血管设备市场供应商的绩效评估

FPNV定位矩阵是评估心血管器材市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，以规划心血管设备市场的成功之路

心血管设备市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 心血管疾病负担增加
      • 人们对微创手术的兴趣日益浓厚
      • 改善新兴经济体的医疗设施并扩大医疗服务范围
    • 抑制因素
      • 严格的监管政策和产品召回
    • 机会
      • 整合穿戴技术持续监测心臟健康
      • 持续研究心血管设备的生物相容性与材料科学
    • 任务
      • 退款政策数量有限
  • 市场区隔分析
    • 设备类型：血压监测仪的快速采用对于高血压的诊断和管理至关重要
    • 最终使用者：门诊手术中心心血管设备使用的演变
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依设备类型分類的心血管设备市场

  • 诊断和监测设备
    • 血压计
    • 心臟 CT 和 MRI 扫描仪
    • 心电图仪
    • 心电图监测
    • 远端心臟监测
    • 压力测试系统
  • 治疗及手术设备
    • 人工心臟
    • 心导管电气烧灼术导管
    • 冠状动脉导管导引线
    • 心臟监测仪
    • 心臟瓣膜
    • 植入式心臟整流去颤器
    • 心律调节器
    • 支架
    • 辅助人工心臟

第七章依适应症分類的心血管器材市场

  • 心律不整
  • 冠状动脉疾病
  • 心臟衰竭
  • 周边动脉疾病

第八章心血管设备市场：依最终用户分类

  • 门诊手术中心
  • 医院
  • 专科诊所

第九章美洲心血管器械市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太心血管器材市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲的心血管器材市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 强生以 131 亿美元收购 Shockwave Medical，以加强心血管护理服务
    • Medtronic)和心臟设计实验室 (Cardiac Design Labs) 在印度推出创新的外部循环记录器技术
    • InfoBionic 的 MoMe ARC 获得 FDA核准，堪称心臟监测领域的一场革命
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • ACS Diagnostics
  • Alivecor, Inc.
  • Asahi Kasei Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Bexen Medical
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • BPL Medical Technologies Private Limited
  • GE Healthcare
  • HeartFlow Holding, Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips NV,
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • Microport Scientific Corporation
  • Nihon Kohden Corporation
  • Qardio, Inc.
  • Schiller AG
  • Terumo Medical Corporation
  • Tricog Health
  • Vesalius Cardiovascular Inc.
  • Zoll Medical Corporation
Product Code: MRR-D2073C5D8E6E

The Cardiovascular Devices Market was valued at USD 53.69 billion in 2023, expected to reach USD 57.55 billion in 2024, and is projected to grow at a CAGR of 7.38%, to USD 88.40 billion by 2030.

The cardiovascular devices market encompasses the broad spectrum of medical devices used to diagnose, manage, and treat cardiovascular diseases. This includes diagnostic devices like electrocardiograms, therapeutic devices such as stents and pacemakers, and monitoring devices that help in tracking chronic conditions like hypertension. The necessity of cardiovascular devices stems from the growing global prevalence of cardiovascular diseases, driven by aging populations, sedentary lifestyles, and rising incidences of diabetes and obesity. They find application in hospitals, surgical centers, and at-home care settings, primarily used by cardiologists and healthcare professionals specializing in heart health. Increasing adoption of minimally invasive procedures and continuous technological advancements in smart medical devices serve as major growth drivers. Major opportunities lie in the development of AI-powered diagnostic tools and patient-specific solutions in personalized medicine, which align with the ongoing digital healthcare transformation. However, limitations such as high costs, stringent regulatory frameworks, and lack of access in underdeveloped regions pose significant challenges. The market also faces hurdles through medical device recalls and cybersecurity threats in connected devices. Innovation should focus on enhancing device connectivity and integration with electronic health records (EHRs) to promote better care coordination. Key areas to explore include predictive analytics for early disease detection and improvements in biocompatibility and battery life for implantable devices. The nature of the market is highly competitive with substantial investment in R&D necessary to maintain technological leadership. Companies should explore partnerships with technology firms to foster product innovation and scalability. Additionally, expanding outreach through training programs for healthcare providers could potentially tackle issues related to device operability and maintenance, with an emphasis on markets with healthcare infrastructure deficits.

KEY MARKET STATISTICS
Base Year [2023] USD 53.69 billion
Estimated Year [2024] USD 57.55 billion
Forecast Year [2030] USD 88.40 billion
CAGR (%) 7.38%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiovascular Devices Market

The Cardiovascular Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing burden of cardiovascular diseases
    • Rising preference for minimally invasive procedures
    • Improved healthcare facilities and the expanding reach of healthcare services in emerging economies
  • Market Restraints
    • Stringent regulatory policies and product recalls
  • Market Opportunities
    • Integration of wearable technology for continuous monitoring of heart health
    • Ongoing research in the biocompatibility and material science of cardiovascular device
  • Market Challenges
    • Limited number of reimbursement policies

Porter's Five Forces: A Strategic Tool for Navigating the Cardiovascular Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiovascular Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiovascular Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiovascular Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiovascular Devices Market

A detailed market share analysis in the Cardiovascular Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiovascular Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiovascular Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiovascular Devices Market

A strategic analysis of the Cardiovascular Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiovascular Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, ACS Diagnostics, Alivecor, Inc., Asahi Kasei Corporation, B. Braun SE, Baxter International Inc., Bexen Medical, Biotronik SE & Co KG, Boston Scientific Corporation, BPL Medical Technologies Private Limited, GE Healthcare, HeartFlow Holding, Inc., Johnson & Johnson Services, Inc., Koninklijke Philips N.V.,, Lepu Medical Technology(Beijing)Co., Ltd., LivaNova PLC, Medtronic PLC, Microport Scientific Corporation, Nihon Kohden Corporation, Qardio, Inc., Schiller AG, Terumo Medical Corporation, Tricog Health, Vesalius Cardiovascular Inc., and Zoll Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiovascular Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Device Type, market is studied across Diagnostic & Monitoring Devices and Therapeutic & Surgical Devices. The Diagnostic & Monitoring Devices is further studied across Blood Pressure Monitors, Cardiac CT & MRI Scanners, Electrocardiogram Devices, Holter Monitors, Remote Cardiac Monitoring, and Stress Test Systems. The Therapeutic & Surgical Devices is further studied across Artificial Hearts, Cardiac Ablation Catheters, Coronary Guidewires, Heart Monitors, Heart Valves, Implantable Cardioverter Defibrillators, Pacemakers, Stents, and Ventricular Assist Devices.
  • Based on Indication, market is studied across Cardiac Arrhythmia, Coronary Artery Disease, Heart Failure, and Peripheral Arterial Disease.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing burden of cardiovascular diseases
      • 5.1.1.2. Rising preference for minimally invasive procedures
      • 5.1.1.3. Improved healthcare facilities and the expanding reach of healthcare services in emerging economies
    • 5.1.2. Restraints
      • 5.1.2.1. Stringent regulatory policies and product recalls
    • 5.1.3. Opportunities
      • 5.1.3.1. Integration of wearable technology for continuous monitoring of heart health
      • 5.1.3.2. Ongoing research in the biocompatibility and material science of cardiovascular device
    • 5.1.4. Challenges
      • 5.1.4.1. Limited number of reimbursement policies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Device Type: Burgeoning adoption of blood pressure monitors essential for diagnosing and managing hypertension
    • 5.2.2. End-User: Evolving utilization of cardiovascular devices across the ambulatory surgical centers
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cardiovascular Devices Market, by Device Type

  • 6.1. Introduction
  • 6.2. Diagnostic & Monitoring Devices
    • 6.2.1. Blood Pressure Monitors
    • 6.2.2. Cardiac CT & MRI Scanners
    • 6.2.3. Electrocardiogram Devices
    • 6.2.4. Holter Monitors
    • 6.2.5. Remote Cardiac Monitoring
    • 6.2.6. Stress Test Systems
  • 6.3. Therapeutic & Surgical Devices
    • 6.3.1. Artificial Hearts
    • 6.3.2. Cardiac Ablation Catheters
    • 6.3.3. Coronary Guidewires
    • 6.3.4. Heart Monitors
    • 6.3.5. Heart Valves
    • 6.3.6. Implantable Cardioverter Defibrillators
    • 6.3.7. Pacemakers
    • 6.3.8. Stents
    • 6.3.9. Ventricular Assist Devices

7. Cardiovascular Devices Market, by Indication

  • 7.1. Introduction
  • 7.2. Cardiac Arrhythmia
  • 7.3. Coronary Artery Disease
  • 7.4. Heart Failure
  • 7.5. Peripheral Arterial Disease

8. Cardiovascular Devices Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Hospitals
  • 8.4. Specialty Clinics

9. Americas Cardiovascular Devices Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cardiovascular Devices Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cardiovascular Devices Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Johnson & Johnson Acquires Shockwave Medical for USD 13.1 Billion, Bolstering Its Cardiovascular Care Offerings
    • 12.3.2. Medtronic and Cardiac Design Labs Unveil Revolutionary External Loop Recorder Technology in India
    • 12.3.3. InfoBionic's MoMe ARC Receives FDA Approval for Revolutionizing Cardiac Monitoring
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. ACS Diagnostics
  • 3. Alivecor, Inc.
  • 4. Asahi Kasei Corporation
  • 5. B. Braun SE
  • 6. Baxter International Inc.
  • 7. Bexen Medical
  • 8. Biotronik SE & Co KG
  • 9. Boston Scientific Corporation
  • 10. BPL Medical Technologies Private Limited
  • 11. GE Healthcare
  • 12. HeartFlow Holding, Inc.
  • 13. Johnson & Johnson Services, Inc.
  • 14. Koninklijke Philips N.V.,
  • 15. Lepu Medical Technology(Beijing)Co., Ltd.
  • 16. LivaNova PLC
  • 17. Medtronic PLC
  • 18. Microport Scientific Corporation
  • 19. Nihon Kohden Corporation
  • 20. Qardio, Inc.
  • 21. Schiller AG
  • 22. Terumo Medical Corporation
  • 23. Tricog Health
  • 24. Vesalius Cardiovascular Inc.
  • 25. Zoll Medical Corporation

LIST OF FIGURES

  • FIGURE 1. CARDIOVASCULAR DEVICES MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIOVASCULAR DEVICES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. CARDIOVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. CARDIOVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CARDIOVASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIOVASCULAR DEVICES MARKET DYNAMICS
  • TABLE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC CT & MRI SCANNERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTROCARDIOGRAM DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REMOTE CARDIAC MONITORING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STRESS TEST SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ARTIFICIAL HEARTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ABLATION CATHETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY GUIDEWIRES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART MONITORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VENTRICULAR ASSIST DEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL ARTERIAL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. AUSTRALIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. INDONESIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. JAPAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. MALAYSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. PHILIPPINES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SINGAPORE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. SOUTH KOREA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. TAIWAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. THAILAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. VIETNAM CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. DENMARK CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. EGYPT CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FINLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. FRANCE CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. GERMANY CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ISRAEL CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. ITALY CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NETHERLANDS CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NIGERIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. NORWAY CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. POLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. QATAR CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. RUSSIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SAUDI ARABIA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SOUTH AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SPAIN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWEDEN CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. SWITZERLAND CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. TURKEY CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED ARAB EMIRATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC & SURGICAL DEVICES, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 244. UNITED KINGDOM CARDIOVASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 245. CARDIOVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 246. CARDIOVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2023